• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOSPHERE MEDICAL S.A. EMBOSPHERE; DEVICE, VASCULAR, FOR PROMOTING EMBOLIZATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOSPHERE MEDICAL S.A. EMBOSPHERE; DEVICE, VASCULAR, FOR PROMOTING EMBOLIZATION Back to Search Results
Catalog Number S020GH
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Fever (1858); Sepsis (2067); Hematuria (2558); Implant Pain (4561)
Date of Event 02/26/2024
Type of Reportable Event Serious Injury
Event or Problem Description
The publication describes multiple serious injury events summarized in aggregate form without complete patient-level detail.Therefore, the manufacturer is submitting a consolidated literature-based mdr representing the serious injury event type described in the article.Study: study: capocasale, e., larini, p., mazzoni, m.P., marcato, c., valle, r.D., busi, n., monaco, d., benozzi, l., & sianesi, m.(2005).Percutaneous renal artery embolization of nonfunctioning allograft: preliminary experience.Transplantation proceedings, 37(6), 2523-2524.Https://doi.Org/10.1016/j.Transproceed.2005.06.016 was reviewed during internal quality system activities.The publication describes that the microspheres used in percutaneous renal artery embolization (prae) procedures have been associated with hematuria, and septic fever.Echocolor doppler and clinical evaluation was scheduled at discharge and repeated at the 1, 3, 6, and 12 months follow-up.Immediate technical success was achieved in all cases; no complications occurred.In 3 cases, complete resolution of the syndrome was obtained.One patient with persisting hematuria underwent angiography that disclosed a perirenal collateral circulation originating from a lumbar artery, which was successfully embolized.One patient underwent a transplant nephrectomy because of septic fever.A post-embolization syndrome of fever and graft pain was observed in 2 of the 5 cases but resolved spontaneously in 3-4 days.The average hospital stay was 6 days.At 12 months follow-up, echocolor doppler showed the same size of the kidney in 3 cases, a 30% reduction in bipolar diameter in 1, and absence of flow in all cases.
 
Additional Manufacturer Narrative
This event was identified during internal quality system activities involving retrospective review of literature sources.Upon review, the manufacturer determined the event meets applicable medical device reporting criteria and is submitting this report to ensure completeness of complaint and mdr documentation.This submission does not represent new information regarding device performance or a change in the known risk profile of the device.The suspect device was not returned for evaluation.Device lot information was not available from the publication; therefore, a review of manufacturing records and complaint trending specific to the device lot could not be performed.Based on the information available from the literature source, the complaint could not be confirmed, and a definitive root cause could not be determined.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EMBOSPHERE
Common Device Name
DEVICE, VASCULAR, FOR PROMOTING EMBOLIZATION
Manufacturer (Section D)
BIOSPHERE MEDICAL S.A.
parc des nations paris nord 2
383 rue de la belle etoile
roissy-en-france, 95700
FR  95700
Manufacturer (Section G)
BIOSPHERE MEDICAL S.A.
parc des nations paris nord 2
383 rue de la belle etoile
roissy-en-france, 95700
FR   95700
Manufacturer Contact
marie-laure patucca
parc des nations paris nord 2
383 rue de la belle etoile
roissy-en-france, 95700
FR   95700
MDR Report Key25803133
Report Number9615728-2026-00091
Device Sequence Number6000284
Product Code KRD
UDI-Device Identifier00884450402948
UDI-Public00884450402948
Combination Product (Y/N)N
Initial Reporter StateUT
Initial Reporter CountryUS
PMA/510(K) Number
K181300
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,Literature,Health Professional,Company Representative
Initial Reporter Occupation Other
Type of Report Initial
Report Date (Section B) 07/13/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Catalogue NumberS020GH
Was Device Available for Evaluation? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 02/26/2024
Initial Report FDA Received Date07/13/2026
Was Device Evaluated by Manufacturer? (Y/N) No
Usage of Device Unknown
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention; Hospitalization; Disability; Other;
Patient SexUnknown
-
-